• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来酸罗格列酮漂浮微球的研制及体外评价。

Development and in vitro evaluation of floating rosiglitazone maleate microspheres.

机构信息

AISSMS College of Pharmacy, Kennedy Road, Pune, India.

出版信息

Drug Dev Ind Pharm. 2009 Jul;35(7):834-42. doi: 10.1080/03639040802627421.

DOI:10.1080/03639040802627421
PMID:19337874
Abstract

BACKGROUND

Various approaches have been used to retain the dosage form in stomach as a way of increasing the gastric residence time, including floatation systems; high-density systems; mucoadhesive systems; magnetic systems; unfoldable, extensible, or swellable systems; and superporous hydrogel systems.

AIM

The objective of this study was to prepare and evaluate floating microspheres of rosiglitazone maleate for the prolongation of gastric residence time.

METHOD

The microspheres were prepared by solvent diffusion-evaporation method using ethyl cellulose and hydroxypropylmethylcellulose. A full factorial design was applied to optimize the formulation.

RESULTS

Preliminary studies revealed that the polymer:drug ratio, concentration of polymer, and stirring speed significantly affected the characteristics of microspheres. The optimum batch exhibited a prolonged drug release, remained buoyant for >12 hours, high entrapment efficiency, and particle size in the order of 350 microm.

CONCLUSION

The results of 32 full factorial design revealed that the concentration of ethylcellulose 7 cps (X(1)) and stirring speed (X(2)) significantly affected drug entrapment efficiency, percentage release after 8 h and particle size of microspheres.

摘要

背景

为了延长胃内停留时间,提高药物生物利用度,人们研究了多种方法来保持药物剂型在胃内的状态,包括漂浮系统、高密度系统、黏膜黏附系统、磁系统、可展开、可拉伸或可膨胀系统以及超多孔水凝胶系统。

目的

本研究旨在制备和评价马来酸罗格列酮漂浮微球,以延长胃内停留时间。

方法

采用溶剂扩散-蒸发法,以乙基纤维素和羟丙甲纤维素为载体材料制备微球。采用完全析因设计优化处方。

结果

初步研究表明,聚合物与药物的比例、聚合物浓度和搅拌速度对微球的性质有显著影响。最优批次微球具有延长的药物释放、>12 小时的持续漂浮、高包封效率和 350μm 左右的粒径。

结论

32 次完全析因设计的结果表明,乙基纤维素 7cps(X1)的浓度和搅拌速度(X2)显著影响药物包封效率、8 小时后的释放百分比和微球的粒径。

相似文献

1
Development and in vitro evaluation of floating rosiglitazone maleate microspheres.马来酸罗格列酮漂浮微球的研制及体外评价。
Drug Dev Ind Pharm. 2009 Jul;35(7):834-42. doi: 10.1080/03639040802627421.
2
Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.马来酸罗格列酮缓释漂浮微球的制备以提高生物利用度。
Pharmazie. 2010 Jul;65(7):477-80.
3
Gastric retentive drug-delivery systems.胃滞留型药物递送系统
Crit Rev Ther Drug Carrier Syst. 1998;15(3):243-84.
4
Formulation and evaluation of mucoadhesive dosage form containing rosiglitazone maleate.含马来酸罗格列酮的黏膜黏附剂型的制备与评价
Pak J Pharm Sci. 2006 Jul;19(3):208-13.
5
Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.胃滞留型制剂:综述,特别强调漂浮型药物传递系统。
Drug Deliv. 2011 Feb;18(2):97-110. doi: 10.3109/10717544.2010.520354. Epub 2010 Oct 20.
6
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.胃滞留剂型:概述及幽门螺杆菌的特殊情况
J Control Release. 2006 Mar 10;111(1-2):1-18. doi: 10.1016/j.jconrel.2005.10.031. Epub 2006 Jan 5.
7
Development and evaluation of pulsatile drug delivery system using novel polymer.新型聚合物脉动式给药系统的研发与评价
Pharm Dev Technol. 2009;14(4):380-7. doi: 10.1080/10837450802712625.
8
A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations.不同释药装置体外-体内相关性研究在缓控释制剂中的应用。
Eur J Pharm Biopharm. 2009 Sep;73(1):115-20. doi: 10.1016/j.ejpb.2009.04.012. Epub 2009 May 13.
9
A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.一种新型的尼群地平pH依赖性梯度释放给药系统II。影响该系统释放行为的因素研究。
Int J Pharm. 2004 Nov 22;286(1-2):99-109. doi: 10.1016/j.ijpharm.2004.08.007.
10
In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.乳液溶剂扩散法制备的中空微球(微球囊)的漂浮及释药行为的体外评价
Eur J Pharm Biopharm. 2004 Mar;57(2):235-43. doi: 10.1016/S0939-6411(03)00185-1.

引用本文的文献

1
A Current Overview of Cyclodextrin-Based Nanocarriers for Enhanced Antifungal Delivery.用于增强抗真菌递送的环糊精基纳米载体的当前概述
Pharmaceuticals (Basel). 2022 Nov 22;15(12):1447. doi: 10.3390/ph15121447.
2
An Overview of Microparticulate Drug Delivery System and its Extensive Therapeutic Applications in Diabetes.微颗粒药物递送系统概述及其在糖尿病中的广泛治疗应用
Adv Pharm Bull. 2022 Aug;12(4):730-746. doi: 10.34172/apb.2022.075. Epub 2021 Oct 4.
3
Comparative evaluation of porous versus nonporous mucoadhesive films as buccal delivery system of glibenclamide.
比较多孔与非多孔黏膜粘附性薄膜作为格列本脲颊部给药系统的效果。
AAPS PharmSciTech. 2013 Dec;14(4):1321-32. doi: 10.1208/s12249-013-0014-6. Epub 2013 Aug 30.